MAX dimerization protein MGA (MGA) (MGA)

MAX dimerization protein MGA (MGA) is a large transcription factor that plays a pivotal role in the MYC/MAX/MAD network, acting as a primary antagonist to MYC-mediated transcriptional activation. It functions by forming a heterodimer with MAX and binding to specific DNA motifs, such as E-boxes and T-boxes, where it recruits the Polycomb repressive complex 1.6 (PRC1.6) to mediate gene silencing (UniProt Q8IWI9). This regulatory mechanism is essential for controlling cell proliferation and maintaining genomic stability. The MGA gene locus is frequently mutated or deleted in various human malignancies, most notably non-small cell lung cancer (NSCLC) and chronic lymphocytic leukemia (CLL), where its loss leads to the hyperactivation of MYC targets and accelerated tumor growth (Sun et al., 2021; Llabrés et al., 2015). In the field of genomic medicine, the MGA gene locus is considered a target for sequence-specific interventions, such as CRISPR-Cas9, which are utilized in research to investigate the consequences of MGA deficiency or to explore potential therapeutic restoration. Precision in targeting the 'on-target' genomic DNA sequence is critical, as the protein's extensive regulatory network makes it a sensitive node in cellular homeostasis, and off-target effects could lead to unintended oncogenic consequences.

Other names

MAD5MAX gene-associated proteinFunctional domain-containing protein 1MGAD

MGA acts as a transcriptional repressor by binding to E-box and T-box DNA sequences and recruiting the PRC1.6 complex to silence MYC-target genes (Sun et al., 2021; UniProt Q8IWI9).